Ronen Twito

MER Telemanagement Solutions Ltd. engages in the provision of telecom solutions. It offers telecom expense management, call accounting, TEM billing audit, and contact center software. The company was founded on December 27, 1995 and is headquartered in Ra'anana, Israel.

Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel.

Part of Ernst & Young Global Ltd., Kost Forer Gabbay & Kasierer is an Israeli company that offers audit, FAAS, and forensic & integrity services to address risk and identify opportunities to enhance trust in the capital markets. The company is based in Tel Aviv, Israel. The company also has EY-Parthenon teams that help CEOs create long-term value from strategy to execution. Additionally, Kost Forer Gabbay & Kasierer's analytics consulting services utilize the latest technology to integrate data and analytics throughout business processes and operations.

Leadcom Integrated Solutions Ltd. provides telecommunications network deployment services and solutions. Its solutions include civil infrastructure, telecom implementation, in building coverage, operations and maintenance, energy; value added reseller and safe/smart city. The company was founded in 1982 and is headquartered in Or Yehuda, Israel.

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.